Treatment with SRRM4 ASO induced REST expression through alternative splicing, followed by the repression of the abnormal expression of several neuronal genes, such as neuropeptides that function in autocrine growth in SCLC [13, 14, 27]. This evidence concerns the gene SRRM4 and small cell lung carcinoma.